Literature DB >> 19447501

Induction of macrophage migration by neurotoxic prion protein fragment.

Haiyun Zhou1, Xiangmei Zhou, Mohammed Kouadir, Zhongqiu Zhang, Xiaomin Yin, Lifeng Yang, Deming Zhao.   

Abstract

Prion diseases are characterized by accumulation of protease resistant isoforms of prion protein (PrP), and infiltration and activation of mononuclear phagocytes at the brain lesions. Interactions between prion proteins and immune cells during disease progression are still not very well understood. In the present study, multiwell chamber chemotaxis assay was carried out to assess the migratory response of macrophage cell line Ana-1 to a synthetic peptide homologous to residues 106-126 of the human prion protein. Specific protein kinase inhibitors were used to elucidate the signaling events underlying PrP106-126-induced macrophages migration, and a comparison with the signaling pattern of macrophage migration induced by substance P (SP) and N-formyl-methionyl-leucyl-phenylalanine (fMLP), respectively, was carried out. The results showed that PrP106-126 had a potent chemotactic effect on murine macrophage cell line Ana-1; that multiple signaling pathways might be involved in the PrP106-126-induced macrophage migrations; and that PrP106-126-induced chemotactic activity was similar to that induced by SP. These findings provide new insights into the mechanisms underlying the interaction between PrP and macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447501     DOI: 10.1016/j.jneumeth.2009.04.002

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  5 in total

1.  Pathogenic prion protein fragment (PrP106-126) promotes human immunodeficiency virus type-1 infection in peripheral blood monocyte-derived macrophages.

Authors:  Silvia M Bacot; Gerald M Feldman; Kenneth M Yamada; Subhash Dhawan
Journal:  Virology       Date:  2015-01-09       Impact factor: 3.616

2.  Adaptive evolution of formyl peptide receptors in mammals.

Authors:  Yoshinori Muto; Stéphane Guindon; Toshiaki Umemura; László Kőhidai; Hiroshi Ueda
Journal:  J Mol Evol       Date:  2015-01-28       Impact factor: 2.395

3.  Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists.

Authors:  Agostino Cilibrizzi; Igor A Schepetkin; Gianluca Bartolucci; Letizia Crocetti; Vittorio Dal Piaz; Maria Paola Giovannoni; Alessia Graziano; Liliya N Kirpotina; Mark T Quinn; Claudia Vergelli
Journal:  Bioorg Med Chem       Date:  2012-04-27       Impact factor: 3.641

Review 4.  Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists.

Authors:  Fabio Cattaneo; Melania Parisi; Rosario Ammendola
Journal:  Int J Mol Sci       Date:  2013-04-02       Impact factor: 5.923

5.  Incunabular immunological events in prion trafficking.

Authors:  Brady Michel; Crystal Meyerett-Reid; Theodore Johnson; Adam Ferguson; Christy Wyckoff; Bruce Pulford; Heather Bender; Anne Avery; Glenn Telling; Steven Dow; Mark D Zabel
Journal:  Sci Rep       Date:  2012-06-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.